Published April 2019
| Version v1
Journal article
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
Creators
- 1. Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain (France)
- 2. Department of Biostatistics, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, Nantes, St-Herblain (France)
- 3. Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers (France)
- 4. Centre de Recherche en Informatique, Signal et Automatique de Lille, CRIStAL UMR CNRS 9189, Université de Lille, Lille (France)
- 5. Academic Radiation Oncology Department, Centre Oscar Lambret, Lille (France)
Description
Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments. Salvage whole pelvis radiation therapy as considered in the BLINDED trial is an attractive option, but there are concerns about its toxicity. This article describes early toxicity with the technique.
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2018.12.020;
- PII
- S0360301618341865;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 103
- Journal Issue
- 5
- Journal Page Range
- p. 1061-1067
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55057227
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- HORMONES; NEOPLASMS; PELVIS; PROSTATE; RADIOTHERAPY; TOXICITY
- Descriptors DEC
- BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.